WeVote
Log In

Bill

Bill

HB 1382

Public Health - Human Immunodeficiency Virus - Repeal of Prohibition on Transfer and Study

2025 Regular Session Introduced by Heather Bagnall Tudball

Bill repeals Maryland's legal prohibition on HIV sample transfers and research studies, potentially accelerating medical research but raising patient privacy concerns.

Withdrawn by Sponsor
0
WeVote Research Nonpartisan
Bill Summary · HB 1382

Legislative bill overview

HB 1382 would repeal Maryland's existing prohibition on the transfer and study of HIV samples and biological materials. The bill aimed to remove legal restrictions that currently prevent researchers and public health officials from conducting certain types of HIV research and sample transfers without explicit statutory barriers.

Why is this important

HIV research capabilities and sample sharing are essential for developing treatments, vaccines, and improving public health surveillance. Restrictions on transfers and studies can slow medical progress and limit collaborative research efforts between institutions. However, such restrictions typically exist to protect patient privacy and prevent misuse of biological materials.

Potential points of contention

  • Privacy and consent concerns: Removing prohibitions on HIV sample transfers raises questions about whether adequate patient consent and privacy protections remain in place, given HIV's sensitive nature and stigma
  • Alternative regulatory frameworks: Existing restrictions may serve purposes better addressed through oversight mechanisms (IRBs, ethics committees) rather than blanket prohibitions, but repealing the law removes explicit protections
  • Scope ambiguity: The bill's language on what "transfer and study" encompasses could allow broader use of samples than originally intended by patients or donors

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.